医学
月经出血
血管性血友病
贫血
儿科
人口
生活质量(医疗保健)
月经
妇科
血管性血友病因子
内科学
血小板
环境卫生
护理部
作者
Claudia Borzutzky,Julie Jaffray
出处
期刊:JAMA Pediatrics
[American Medical Association]
日期:2019-12-30
卷期号:174 (2): 186-186
被引量:65
标识
DOI:10.1001/jamapediatrics.2019.5040
摘要
Importance
Heavy menstrual bleeding is a common cause of anemia and reduced quality of life in adolescents. There is a higher prevalence of bleeding disorders in girls with heavy menstrual bleeding than in the general population. Pediatricians should be comfortable with the initial evaluation of heavy menstrual bleeding and the indications for referral to subspecialty care. Observations
The most common cause of heavy menstrual bleeding in adolescents is ovulatory dysfunction, followed by coagulopathies. The most common inherited bleeding disorder is von Willebrand disease, and its incidence in adolescents with heavy menstrual bleeding is high. Distinguishing the etiology of heavy menstrual bleeding will guide treatment, which can include hemostatic medications, hormonal agents, or a combination of both. Among hormonal agents, the 52-mg levonogestrel intrauterine device has been shown to be superior in its effect on heavy menstrual bleeding and is safe and effective in adolescents with bleeding disorders. Conclusions and Relevance
Anemia, need for transfusion of blood products, and hospitalization may be avoided with prompt recognition, diagnosis, and treatment of heavy menstrual bleeding, especially when in the setting of bleeding disorders. Safe and effective treatment methods are available and can greatly improve quality of life for affected adolescents. A multidisciplinary approach to the treatment of girls with bleeding disorders and history of heavy menstrual bleeding is optimal.
科研通智能强力驱动
Strongly Powered by AbleSci AI